← Leaderboards
Dr. Greg Westergaard
Alpha Genesis, Inc.
$3,301,951
Attributed
$3,301,951
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$3,301,951 · 1
By mechanism
N01$3,301,951 · 1
Top collaborators
No co-investigators on record.
Most similar at Alpha Genesis, Inc.
Same institution · by research overlap
- Greg Westergaard$47,609,961
Others in their field
Other Emerging Leaders on “Transplantation Tolerance”
- Michelle Lynn Sever · Rho Federal Systems Division, Inc.$32,078,740
- Greg Westergaard · Alpha Genesis Inc$19,914,439
- William H. Peranteau · Children'S Hosp Of Philadelphia$4,881,032
- Mohamed B Ezzelarab · University Of Pittsburgh At Pittsburgh$4,780,131
- Adam David Griesemer · Columbia University Health Sciences$4,625,617
- Thomas Dick · Rbhs-New Jersey Medical School$4,351,064
Research focus
Transplantation ToleranceBreedingContractorContractsCooperative StudyGerm Free ConditionRegimenResearch SupportTransplantationImmune ToleranceMacacaMacaca FascicularisMacaca MulattaMaintenanceNational Institute Of Allergy And Infectious DiseaseNonhuman PrimatePreclinical EfficacyPreclinical SafetyPrimatesImmuneBiodefenseMediating